Concepedia

Wayne Macfadden

WM

Statistics

Publications

28

Citations

3.1K

H-Index

21

Active since

1961

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Johnson & Johnson (United States)

Novartis (Switzerland)

University Hospitals of Cleveland

Wayne Macfadden is an author at Janssen (United States) specializing in pharmacotherapy, psychiatry, and psychopharmacology.

ORCID

Publications per year

1961–2024

28

Publications

28

A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

Joseph R. Calabrese, Paul E. Keck, Wayne Macfadden et al. · American Journal of Psychiatry · 2005 · 881 citations

, , +14

Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression

Michael E. Thase, Wayne Macfadden, Richard H. Weisler et al. · Journal of Clinical Psychopharmacology · 2006 · 559 citations

, , +15

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration

Rufino Silva, András Berta, Michael Larsen et al. · Ophthalmology · 2017 · 259 citations · Full text

, , +17

A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently

Wayne Macfadden, Larry Alphs, J. Thomas Haskins et al. · Bipolar Disorders · 2009 · 178 citations

, , +17

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

Paul J. Fudala, Elmer Yu, Wayne Macfadden et al. · Drug and Alcohol Dependence · 1998 · 120 citations · Full text

, , +11

1–5 of 28